9 Meters Biopharma Inc
(NMTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,646 | 46,993 | 37,851 | 4,593 | 5,729 |
| Other current assets | 17,013 | 0 | 75 | 75 | 180 |
| TOTAL | $33,018 | $49,985 | $38,927 | $5,223 | $6,414 |
| Non-Current Assets | |||||
| PPE Net | 10 | 16 | 11 | 25 | 35 |
| Other Non-Current Assets | 120 | 172 | 220 | 48 | 6 |
| TOTAL | $130 | $188 | $232 | $74 | $41 |
| Total Assets | $33,148 | $50,174 | $39,159 | $5,297 | $6,454 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,053 | 2,435 | 1,488 | 3,890 | 3,619 |
| Accrued Expenses | 4,380 | 5,968 | 5,290 | 4,748 | 826 |
| Other current liabilities | 1,585 | N/A | 7 | 3,046 | 370 |
| TOTAL | $30,696 | $8,457 | $6,849 | $14,911 | $10,113 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 51 | 113 | 168 | 0 | 0 |
| TOTAL | $51 | $113 | $168 | $N/A | $N/A |
| Total Liabilities | $30,747 | $8,570 | $7,016 | $14,911 | $10,113 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,336 | 12,912 | 10,804 | 2,066 | 1,340 |
| Common Shares | 1 | 1 | 21 | 4 | 3 |
| Retained earnings | -212,607 | -168,841 | -132,061 | -70,565 | -43,516 |
| TOTAL | $2,401 | $41,603 | $32,142 | $-9,614 | $-3,659 |
| Total Liabilities And Equity | $33,148 | $50,174 | $39,159 | $5,297 | $6,454 |